Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Carbinoxamine sustained-release orally disintegrating tablets and preparation method thereof

A technology of orally disintegrating tablets and carbinoxamine, which is applied in the field of slow-release orally disintegrating tablets and its preparation, achieves the effects of simple preparation process, high true sphericity, and extremely easy operation

Inactive Publication Date: 2016-11-09
BEIJING VENTUREPHARM BIOTECH
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The technical scheme adopted in the present invention is: firstly, the drug-containing pellets are prepared by using the sustained-release matrix material, and then the drug-containing pellets are coated with the sustained-release coating film to realize the two-way control of the drug release rate by the framework and the film control, so as to continuously At the same time, the slow-release coating layer contains gastric adhesive materials, which can effectively increase the gastric residence time of the preparation, thereby improving the bioavailability of the drug. Finally, add diluents, disintegrating agents, flavoring and corrective agents, and auxiliary agents. Auxiliary ingredients such as fluid lubricants are compressed into orally disintegrating tablets. This dosage form can be directly disintegrated and dispersed in the mouth without water delivery, which effectively solves the problem of swallowing difficulties for children and middle-aged and elderly patients. The characteristics of high utilization can improve the medication compliance of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carbinoxamine sustained-release orally disintegrating tablets and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Prescription composition:

[0024] Sustained-release pellet composition:

[0025] Carbinoxamine 100g

[0026] Lactose 40g

[0027] Hypromellose 40g

[0028] Acrylic resin 10g

[0029] Polyethylene glycol 4g

[0030] Talc powder 2g

[0031] Methylcellulose 4g

[0032] 200g total.

[0033] Sustained-release orally disintegrating tablet composition:

[0034] Carbinoxamine Sustained Release Pellets 150g

[0035] Croscarmellose Sodium 10g

[0036] Mannitol 30g

[0037] Aspartame 4g

[0038] Talc powder 3g

[0039] Menthol 1g

[0040] Magnesium Stearate 2g

[0041] 200g total.

[0042] Preparation Process:

[0043] Preparation of drug-containing pellets: Weigh the raw material of carbinoxamine, add lactose and hypromellose, and mix well; add an appropriate amount of water to the mixed material to make a soft material; put the soft material into an extrusion spheronizer Prepare drug-containing pellets; bake the prepared pellets at 50°C for 3-6 hours to obtain ...

Embodiment 2

[0047] Prescription composition:

[0048] Sustained-release pellet composition:

[0049] Carbinoxamine 100g

[0050] Microcrystalline Cellulose 35g

[0051] Hypromellose 45g

[0052] Ethyl cellulose 10g

[0053] Polyethylene glycol 4g

[0054] Talc powder 2g

[0055] Methylcellulose 4g

[0056] 200g total.

[0057] Sustained-release orally disintegrating tablet composition:

[0058] Carbinoxamine Sustained Release Pellets 150g

[0059] Croscarmellose Sodium 5g

[0060] Microcrystalline Cellulose 35g

[0061] Aspartame 5g

[0062] Talc powder 3g

[0063]Magnesium Stearate 2g

[0064] 200g total.

[0065] Preparation Process:

[0066] Preparation of drug-containing pellets: Weigh the raw material drug of carbinoxamine, add microcrystalline cellulose and hypromellose, and mix well; add an appropriate amount of water to the mixed material to make a soft material; put the soft material into extrusion spheronization Prepare drug-containing pellets in a granulator; dr...

Embodiment 3

[0070] Prescription composition:

[0071] Sustained-release pellet composition:

[0072] Carbinoxamine 100g

[0073] Mannitol 35g

[0074] Hypromellose 45g

[0075] Acrylic resin 10g

[0076] Triethyl citrate 4g

[0077] Talc powder 2g

[0078] Gelatin 4g

[0079] 200g total.

[0080] Sustained-release orally disintegrating tablet composition:

[0081] Carbinoxamine Sustained Release Pellets 150g

[0082] Cross-linked polyvinylpyrrolidone 10g

[0083] Mannitol 30g

[0084] Aspartame 5g

[0085] Talc powder 3g

[0086] Magnesium Stearate 2g

[0087] 200g total.

[0088] Preparation Process:

[0089] Preparation of drug-containing pellets: Weigh the raw material of carbinoxamine, add mannitol and hypromellose, and mix well; add an appropriate amount of water to the mixed material to make a soft material; put the soft material into extrusion, spheronize and granulate Prepare drug-containing pellets in the machine; dry the prepared pellets at 50°C for 3-6 hours to ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to carbinoxamine sustained-release orally disintegrating tablets and a preparation method thereof. The carbinoxamine sustained-release orally disintegrating tablets are prepared from the following components in percentage by weight: 10%-60% of carbinoxamine and active components thereof, 10%-40% of auxiliary materials with sustained releasing effect and 30%-80% of other auxiliary materials. The carbinoxamine sustained-release orally disintegrating tablets are characterized in that (1) the orally disintegrating tablets are prepared by pressing medicine-containing sustained-release pills and the auxiliary materials; (2) each medicine-containing pill comprises a pill core containing the carbinoxamine and the active components thereof, and a sustained-release coating layer in sequence from inside to outside; (3) the releasing of medicines is controlled through the sustained-release coating layer; and (4) the orally disintegrating tablets are prepared and are convenient to orally take, so that the medicine utilization compliance of patients is improved. The pill cores are prepared by mainly adopting an extruding rolling method and a fluidized bed is used for coating; and then the auxiliary materials are added and the mixture is pressed to prepare the orally disintegrating tablets. The medicine-containing pills are uniformly covered with sustained-release coating materials so that the medicines are slowly and uniformly released and the time to peak is delayed; and the plasma drug concentration keeps stable and the medicine administration frequency is reduced, so that the compliance of the patients can be improved. Furthermore, the prepared orally disintegrating tablets can improve the compliance of the patients with difficulty in swallowing, such as children and old people, and have remarkable preparation advantages.

Description

technical field [0001] The invention belongs to the technical field of drug sustained-release preparations, in particular to a sustained-release orally disintegrating tablet containing an active ingredient carbixamine or a pharmaceutically acceptable salt thereof and a preparation method thereof. Background technique [0002] Carbinoxamine is a class of ethanolamine antihistamine drugs with mild sedative effects. It has been proven safe and effective in the past few years and has been widely used in countries all over the world. There are many compound preparations containing carbinoxamine, including solid sustained-release drugs . [0003] Carbinoxamine is very effective in treating allergies in children and is often used to relieve symptoms of anaphylaxis, colds, and coughs. The standard of carbinoxamine maleate ordinary tablet is 4mg, and patients need to take the medicine 3-4 times a day to provide sufficient blood concentration and ensure good therapeutic effect. In a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/26A61K31/4402A61K47/38A61K47/32A61K47/34A61P37/08A61P25/20
CPCA61K9/0056A61K9/2081A61K31/4402A61K47/10A61K47/32A61K47/38
Inventor 张庭马莉
Owner BEIJING VENTUREPHARM BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products